cmuzf
Lv31
320 积分
2023-03-19 加入
-
Clinical impact of postoperative changes in body composition on long-term outcomes in patients with esophageal cancer
1小时前
已完结
-
Safety, Tolerability, and Preliminary Efficacy of Serplulimab, a Novel Anti-PD-1 Antibody, in Patients with Metastatic or Recurrent Solid Tumors: A Phase I Study
1小时前
已完结
-
Prognostic Impact of Hepatic Steatosis Evaluated by CT on Immunotherapy for Gastric Cancer: Associations with Sarcopenia, Systemic Inflammation, and Hormones
2小时前
已完结
-
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
3小时前
已完结
-
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
22天前
已完结
-
Impact of BMI and Body Composition on First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
25天前
已完结
-
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy
25天前
已关闭
-
Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors
26天前
已完结
-
Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis
1个月前
已完结
-
Adverse outcomes and health-ecological influencing factors of preoperative frailty among elderly patients with gastric cancer
1个月前
已完结